Mercia Asset Management Share Discussion Threads

[weatherman] 08/7/2019 09:38

Asset management side worth +10p above stated nav.
hxxps://www.edisongroup.com/company/mercia-technologies/2827

[pavey ark] 08/7/2019 09:10

Bought in here recently and happy with the results and where they are heading.

These first came to my notice with the IC article but unlike a number of PIs I research the company after the article is published and if IF I take the next step (buying the shares) I accept that it was MY decision.

One point made in the IC article that appears to show up in the results is that no asset value is being given to the asset management business.

From memory the IC article suggested that this business is worth c. 24p/share.

The large discount to NAV looks to be even greater than the substantial figure given.

The asset management is in the books at £2.5m goodwill charge on the acquisition in 2014!!

Goodwill (£10m see note 9))+ Portfolio + cash = £122m = 40p

( Obviously I stand to be corrected especially by longer term holders.)

[wan] 08/7/2019 08:26

Overall, I am quite pleased and reassured by the results!

[p1nkfish] 02/7/2019 10:25

Susan Searle going might be due to WPCT issues.
Anyone know what other impact it could have on MERC or major shareholding or AUM?

[redartbmud] 01/7/2019 09:58

Finals 8 July.

[bb123] 01/7/2019 09:51

Please can y help? Any idea when the next results are due?

[turbocharge] 12/6/2019 15:46

Last 12 or so trades at 34.04p showing as sells are actually buys...

[steve3sandal] 11/6/2019 20:55

Simon Thompson in the IC again. Published around 12 o’clock.

[cheshire man] 11/6/2019 16:10

Time will tell TC :-)

[turbocharge] 11/6/2019 16:08

I wonder if it will cross 40p this time

[turbocharge] 11/6/2019 16:07

Lot of trading action today, most of the trades shown as sells are actually buys.

Interesting times...

[p1nkfish] 10/6/2019 15:18

How long before management want to make it easier to get value out of share options by reducing the hurdle?

[redartbmud] 21/5/2019 07:57

Clinically clinical, well, well, well.

[wan] 21/5/2019 07:50

In today's news, Mercia has now described Medherant as a "clinical-stage company", so things are indeed quite advanced!

[cheshire man] 15/5/2019 08:00

Hopefully another good investment :-)

[wan] 10/5/2019 08:01

There has been some very encouraging news flow regarding sodium-ion batteries of late, so watch this space and Mercia's portfolio company Faradion, who is currently leading the field in sodium-ion battery technology.

[aishah] 11/4/2019 15:00

Few directors buying recently

[wan] 28/3/2019 08:25

It's hard to not be impressed with Oxford Genetics, but the market doesn't appear impressed with Mercia's deal of a reduced stake. However, Mercia's reduced interest of 33.3% in OG is worth circa £1m more than the 40.5% stake at the half year. Furthermore, would it be right to assume that such a reduced stake is also easier to manage (by eventually getting below 30%) ahead of the possibility of OG listing?

[cheshire man] 28/3/2019 07:38

Indeed wan,,,,,so much to look forward to here :-)

[wan] 28/3/2019 07:31

Another impressive update regarding Oxford Genetics as it goes global and enters the next phase of growth.

[cheshire man] 12/3/2019 08:00

Looking good

Peter Dines, Chief Operating Officer at Mercia and a non-executive director of Concepta, said: "Securing a partnership with such a leading retailer as Walgreens Boots Alliance is validation that Concepta has developed a product with significant commercial appeal. This new partnership will play a pivotal role in myLotus(R) being more widely available across the UK and overseas."

[wan] 12/3/2019 07:55

Given today's news for portfolio company Concepta, it was a 'fortuitous' mention in the FT, what next then for mentioning/covering Mercia itself?

Hopefully, that the current trend of positive news flow and share price trajectory will persist!

[wan] 09/3/2019 07:07

More media coverage for both Mercia and another one of their portfolio companies, Conepta, this time in the FT -

8th March 2019
Small-cap focus Health Care

Tech helps small players break into healthcare market
Medical device start-ups must go far beyond proof of concept even before they have built a customer base